These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28417613)

  • 1. Combination therapy for complex peripheral artery disease: the evidence for combining mechanical revascularization with anti-restenotic drug delivery systems.
    Varcoe RL
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):722-730. PubMed ID: 28417613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latest developments in SFA management.
    Minar E
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):451-3. PubMed ID: 24941244
    [No Abstract]   [Full Text] [Related]  

  • 4. In-stent restenosis management: the best is yet to come.
    van den Berg JC
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
    Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of drug-coated devices in lower extremity peripheral artery disease interventions.
    Amlani V; Falkenberg M; Nordanstig J
    Prog Cardiovasc Dis; 2021; 65():23-28. PubMed ID: 33587964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
    Lichtenberg MK; Carr JG; Golzar JA
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):518-527. PubMed ID: 28382804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloons for long lesions in peripheral arterial disease.
    Li J; Parikh SA
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):698-714. PubMed ID: 28530090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care?
    Bosiers M; Deloose K; Callaert J; Peeters P; Bosiers M
    J Cardiovasc Surg (Torino); 2016 Dec; 57(6):806-810. PubMed ID: 27647337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery.
    Brahmbhatt A; Misra S
    Tech Vasc Interv Radiol; 2016 Jun; 19(2):145-52. PubMed ID: 27423996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M; Torella F; Antoniou GA
    Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role for DCBs in the treatment of ISR.
    Bague N; Nasr B; Chaillou P; Costargent A; Gouailler-Vulcain F; Goueffic Y
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of drug-coated balloons in in-stent restenosis.
    Andrassy M; Celik S; Andrassy J; Lichtenberg MK; Brodmann M
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):501-507. PubMed ID: 28358184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New devices to cross chronic total occlusion in critical limb ischemia.
    Spanos K; Kouvelos G; Karathanos C; Xhepa S; Athanasios G; Matsagkas M
    J Cardiovasc Surg (Torino); 2016 Dec; 57(6):817-829. PubMed ID: 27647338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Navigating complex femoropopliteal and infrapopliteal anatomy in endovascular interventions.
    Bahia A; Lahsaei S; Bhat T; Garcia L
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):690-697. PubMed ID: 28471153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular intervention for tibial artery occlusive disease in patients with critical limb ischemia.
    Huang ZS; Schneider DB
    Semin Vasc Surg; 2014 Mar; 27(1):38-58. PubMed ID: 25812758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which is currently the best strategy for treatment of SFA in-stent restenosis?
    Elens M; Verbist J; Keirse K; Van Den Eynde W; Peeters P
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):477-81. PubMed ID: 24941234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting balloons in below the knee treatment.
    VAN DEN Berg JC
    J Cardiovasc Surg (Torino); 2016 Dec; 57(6):811-816. PubMed ID: 27654100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.